Clifford Chance has advised Harbin Bank on its HK$8.8 billion (approx. US$1.13 billion) global offering and listing on the Main Board of the Stock Exchange of Hong Kong. The Company sold a total of 3,023,570,000 shares at HK$2.90 each. Harbin Bank started trading in Hong Kong on Monday, 31 March 2014.
The Capital Markets team at Charles Russell LLP has successfully acted for Tekcapital plc on its flotation on the AIM Market, which has been announced today.
This announcement marks a strong start to the year for the team, which is based in London.
The transactions, which announced on 1st April 2014, are: (1) The acquisition of £0.7 billion funds under management of the private client wealth management business of Tilney Investment Management Limited, a subsidiary of Deutsche Bank; (2) The acquisition of £2.1 billion funds under management of Jupiter Asset Management Limited's private client and charity investment management business; and (3) The £24.4 million share placing with existing institutional investors.
Slaughter and May, Hong Kong, is advising CITIC Securities Corporate Finance (HK) Limited on the cash offer it will make on behalf of a controlling shareholder (Offeror) of China XLX Fertiliser Ltd. (China XLX) for the shares of China XLX. The cash offer will be made in connection with the proposal to delist the shares of China XLX from the Singapore Exchange, and will be conditional upon the approval of the delisting proposal by China XLX's shareholders.
Top 20 business law firm DWF has advised Custodian REIT plc, a £130 million closed-ended investment company, on its flotation on the Main Market of the London Stock Exchange. Custodian REIT plc, a newly incorporated company formed by Mattioli Woods plc, is expected to become a real estate investment trust. The flotation is believed to be the first UK REIT IPO to combine a fundraising with the acquisition of a seed portfolio of properties.
A cross-disciplinary Dentons team advised long-time client Amber Road in its recent US$110 million initial public offering (IPO) on the New York Stock Exchange. The team was led by New York and Short Hills Venture Technology partners Victor Boyajian and Ira Kotel.
European law firm Field Fisher Waterhouse has advised Panmure Gordon (UK) Limited in connection with the admission to AIM of Cambridge-based medical technology pioneer Horizon Discovery Group plc. Panmure acted as nominated adviser and broker to Horizon.
Horizon was admitted to AIM today with a market capitalisation of £120.5 million. Panmure raised approximately £68.5 million from institutional investors on behalf of Horizon and selling shareholders. This is one of the largest fundraisings on AIM this year.
International law firm Simmons & Simmons has advised Venture Life Group plc on its merger with an Italian development and manufacturing company Biokosmes, and on its AIM IPO.
Venture Life is an international consumer healthcare company based in the UK and focused on developing products for the ageing population. The Group’s products are currently sold or partnered in over 40 countries. Biokosmes was founded in Italy in 1983, develops and manufactures topical products, such as cosmetics, dermo-cosmetics and medical devices.
Hogan Lovells advised Macquarie Capital Securities Limited ("Macquarie") and Standard Chartered Securities (Hong Kong) Limited ("Standard Chartered"), as bookrunners and placing agents, on the sale of 600 million existing shares in Tongda Group Holdings Limited ("Tongda") by Landmark Worldwide Holdings Limited ("Landmark Worldwide") and the subscription of the same number of new shares by Landmark Worldwide, raising approximately HK$672 million (US$86.7 million). Landmark Worldwide is Tongda's controlling shareholder.
Paul Hastings LLP represented BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a pharmaceutical company that develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, in connection with its underwritten public offering of 1,500,000 shares of common stock. BioMarin estimated the offering would raise gross proceeds of approximately $119.3 million before costs.
BofA Merrill Lynch acted as underwriter for the offering.